1
BE of Euthyrox® Tablets (Merck Nantong Versus Merck Darmstadt Sites)
Condition(s):HealthyLast Updated:November 25, 2022Completed
Levothyroxine Sodium: 497 Clinical Trials, Page 1 of 50
Hide Studies Not Open or Pending
2
Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form
Condition(s):HealthyLast Updated:September 29, 2020Completed
3
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Condition(s):Hypothyroidism;PostablativeLast Updated:April 5, 2022Completed
4
A Comparative Study of New Formulation and Approved Formulation for Levothyroxine in Healthy Volunteers
Condition(s):HealthyLast Updated:February 5, 2021Completed
5
Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women
Condition(s):Recurrent Early Pregnancy Loss; Thyroid DiseasesLast Updated:September 14, 2023Completed
6
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
Condition(s):HypothyroidismLast Updated:September 22, 2021Withdrawn
7
Evaluation of Evening Versus Morning Levothyroxine Intake in Elderly
Condition(s):Aging; Primary Hypothyroidism; Interaction Drug FoodLast Updated:October 14, 2019Unknown status
8
Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism
Condition(s):Congenital HypothyroidismLast Updated:May 12, 2022Completed
9
Use of Tirosint®-SOL or Tablet Formulations of Levothyroxine in Pediatric Patients With Congenital Hypothyroidism (CH)
Condition(s):Congenital HypothyroidismLast Updated:July 28, 2023Recruiting
10
Comparison of Levothyroxine Formulation in Hypothyroid Patients With Enteral Feeding
Condition(s):HypothyroidismLast Updated:April 10, 2023Terminated